Injection of murine recombinant interleukin-3 (IL-3) into (C57BL/IO X DBA/2)F1 mice, sublethally irradiated with 300 cGy and killed 14 days later, induced in the thymus recovery of the cell number and mitotic responsiveness to concanavalin A (Con A), as well as an increase in number of double-negative CD4-CD8-, double-positive C M + CD8+, and single-positive CD4+CD8-and C M -C D 8 ' cells. Also in the spleen, the cell count and mitotic responsiveness to Con A and lipopolysaccharide were increased NTERLEUKIN-3 (IL-3) is a multilineage colony-stimulating factor (CSF) that is involved in blood cell formation.' IL-3 is a glycoprotein of 15 to 17 kD produced by activated T lymphocytes. It stimulates survival and proliferation of pluripotent stem cells and promotes colony formation by multipotential progenitor cells committed to the granulocyte, macrophage, neutrophil, erythrocyte, eosinophil, megakaryocyte, and mast cell lineages.24 IL-3 is also required for the survival and proliferation of some immortalized myeloid and mast cell lines in vitro.5 IL-3 induces the expression of Thy 1 antigen on normal bone marrow (BM) cells and splenocytes from nude mice as well as of 20 a-hydroxysteroid dehydrogenase activity on splenic lymphocytes from nude mice.6 IG3 promotes the in vitro differentiation and expansion of BM cells into cells displaying natural cytotoxi~ity.~~~ In addition, it enhances the expression of macrophage-CSF receptors on monocytes, tumor necrosis factor-dependent monocyte cytotoxicity' and the production and release of intracellular histamine by basophils in response to the complement factor C5a,1° suggesting that IL-3 is a recruitment factor for activated inflammatory cells. IL-3 has also been shown to support the growth of fetal liver-derived pre-B cells and clones," as well as to induce Ig secretion by activated B cells or B-cell lines.I2 At variance with these findings, Ihle et a l l 3 have reported that IL-3 is unable to induce expression of B-cell antigens on marrow-derived cell lines. As regard to T cells, the reported effects of IL-3 seem to be primarily caused by stimulation of accessory cells present in the lymphocyte preparati~n'~ rather than to the reported effect of IG3 on T-cell c10nes.I~ Nonetheless, a few reports16"* have indicated CD4-CD8-thymocytes as possible targets for IL-3 action.
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In this report, we present evidence that IL-3 induces recovery of T-and B-cell counts and functions in mice immunodepressed by sublethal (200 to 500 cGy) irradiation, suggesting an effect of IL-3 on growth and differentiation of T and B lymphocytes.
I

MATERIALS AND METHODS
Animals.
Female (C57BL/10 X DBA/2) F1 mice, bred and maintained in our animal facilities, were used at the age of 3 to 4 months. Irradiation procedure. Mice were total-body irradiated (200 to 500 cGy) in a lucite chamber, 7 to 28 days before they were killed. The x-ray machine (Stabilipan, Siemens, Germany) was operated at 250 kV, 15 mA, 0.5 mm Cu filtration, dose rate 129 &y/min in air, focus distance 50 cm. to normal levels by IL-3 treatment. If the assays were performed 21 or 28 days after irradiation, IL-3 treatment was able to restore thymus and spleen cell counts as well as Tand B-cell mitotic responsiveness, even when mice were exposed to 400 or 500 cGy, respectively. These results altogether indicate that IL-3 induces differentiation and growth of thymocytes and recovery of T-and B-cell functions in mice exposed to sublethal irradiation. 0 1994 by The Americen Society of Hematology.
IL-3 treatment. Irradiated mice were left uninjected or were injected subcutaneously every day with 0.1 mL phosphate-buffered saline (PBS), supplemented with 0.1% bovine serum albumin, alone or containing 5 pg of murine recombinant IL-3 (murIL3), for 5 consecutive days starting immediately after irradiation. MurlL-3, provided by Genzyme (Cambridge, MA), had a biologic activity of 7 X IO6 U/mg and was devoid of detectable endotoxin as determined by the limulus amebocyte lysate assay.
Cell culture. Mice were individually tested. Two unirradiated and three irradiated, PBS-or IL-3-injected, mice/group were killed by decapitation, their thymuses and spleens were aseptically removed and single cell suspensions were prepared. Cell cultures were performed in microtissue culture plates (Falcon 3040, Oxnard, CA) in RPM1 1640 medium (GIBCO, Grand Island, NY) supplemented with 10% fetal calf serum (Flow Labs, Irvine, UK), 2 mmol/L Lglutamine (GIBCO), 10 pglmL gentamicin (Shering, Kenilworth, NY), and 2 X lo-' mol/L 2-mercaptoethanol. This supplemented medium is hereafter referred to as complete medium.
Thymocyte milotic response to concanavalin A (Con A). The number of cells/thymus was determined and then thymocyte suspensions were cultured in triplicate at 37'C in a 5% CO2 humidified incubator, for 48 hours. Each culture contained lo6 cells in 0.2 mL complete medium alone or with 0.5 to 2 pg Con A.
Four hours before harvesting, cultures received 0.5 pCi of tritiated thymidine (specific activity 1.739 GBq/mmol) (Amersham International, Amersham, UK) in 20 pL, and then were sacrificed with an automated cell harvester (Micromate 196; Packard, Meriden, CT). Radioactivity was measured in a Matrix 96 direct betacounter (Packard) and expressed as cpm/culture. Cytofluorimetric analysis of thymocytes. The reagents used to detect CD4 and CD8 antigens were anti-L3T4 phycoerythrin (PE)-conjugated monoclonal antibody (clone GK 1 S ) and anti-Lyt 2.2 fluorescein isothiocyanate (FITC)-conjugated MoAb (clone 53-6.7), respectively. The reagents were purchased from Becton Dickinson (Mountain View, CA) and optimal concentrations were determined in preliminary experiments. Thymocytes were incubated with anti-CD4 PE-conjugated MoAb and anti-CD8 FITC-conju- 
RESULTS
In preliminary expel-iments, we have studied the kinetics ofthe spontaneous recovery ofT and B cells in mice exposed to different doses ofsublethal irradiation. Briefly, mice were total-body irradiated with 200 to 400 cGy, killed 7 to 28 days later and their thymuses and spleens individually assayed for cellularity, thymocyte mitotic response to Con A, and splenocyte mitotic responses to Con A and LPS. Results in Fig l show that the total number ofthymocytes is drastically decrcased by irradiation at days 7 and 14, and then completely recovered at day 2 1 after 200 and 300, but not after 400 cGy. The thymocyte mitotic response to Con A is also profoundly depressed by irradiation at days 7 and 14. At day 2 I , it appears that 200 and 300 cGy induced only slight eir'ects on thymocyte proliferation, whereas after 400 cGy thc response was twice as high as that of unirradiatcd controls. At day 28, no difference between the response of unirradiated and irradiated groups was found. Also in the spleen, 200 and 300 cGy induced a striking depression in cellularity at day 7 that returned to normal values by day 14 and 21, respectively. Spleen cellularity in mice exposed to 400 cGy dropped to undiscernible values at day 7, was partially recovered by day 14 hut never reached the level ofunirradiated controls. Spleen cell proliferation to T-and B-cell mitogens was profoundly depressed by irradiation at days 7 and 14. Con A response was complctely recovered at days 21 and 28, whereas LPS response was still impaired to a large extent at day 2 1 and to a lower degree at day 28. The effects ofirradiaiion on thymocyte phenotypes arc shown in I n our previous study." we showed that five daily injections of 11,-3, starting immediately after 200 cGy, induced recovery ofcell count and mitotic responsiveness in thymus and spleen ifthc assays were performed 1 week after irradiation. However, this treatment was ineffective if mice were irradiated with 300 cGy and assayed 7 days later. In the present study, we have investigated the etfect of live daily injcctions of 11>-3, starting immediately after 300 cGy, on thymocyte and splenocyte cellularity, thymocyte mitotic response to Con A, and splenocyte mitotic responses to Con A and LPS, when the assays were performed 2 weeks after irradiation. Results presented in Table 1 show that the total number of thymus cells is slightly reduced by 300 cGy, suggesting that spontaneous recovery ofthe cell count is taking place. However, injection of irradiated mice with IL-3 increased. to a great extent, Ihc thymocyte cell number that reached a higher value than i n unirradiated controls. The thymocyte mitotic responsiveness to Con A is more profoundly decreased by irradiation and completely restored by IL-3 administration. Also the spleen cellularity is reduced by 300 cGy and significantly increased by IL-3 injection. The mitotic responsiveness to Con A or LPS, which is slightly reduced by this radiation dose, is also increased in IL-3-injected mice up to the level of unirradiated controls. Injection of IL-3 in mice irradiated with 400 cGy and sacrificed I4 days later failed to induce recovery in thymus and spleen cell counts and functions. Table I also shows the eKects of IL-3 injection in mice irradiated with 400 cCy, 2 I days before thcy were killed. This dose of irradiation induced a significant decrease in both thymocyte number and mitotic responsiveness to Con A, which were fully recovered by IL-3 administration. The splenocyte number and mitotic responses to Con A and LPS were also profoundly decreased by irradiation and increased by IL-3 injection up to the level of unirradiated controls. When mice were exposed to 500 cCy, IL-3 injection was able to induce significant recovery of thymocyte and splenocyte counts and mitotic responses when the assays were performed 28 days after irradiation. However, if the time interval between this radiation dose and death was less than 28 days, [L-3 injection was found ineffective.
FACS analysis of thymocyte phenotypes from unirradiatcd mice and from 300-to 500-cGy-treated mice, uninjected or illjected with IL-3, are shown in Table 2 . The most evident effect of irradiation with 300 cGy is at the level of CD4 C D 8 ~ cells as their absolute number is much more decreased than that of the other cell subsets. 1L-3 treatment was effective on all cell subpopulations that recovered in cell numbers above normal controls. FACS analysis of thymocytes from 400-cCy-treated mice showed an appreciable reduction in the cell numbers of all subpopulations, but mostly of CD4-CD8-and CD4ICD8 ' cells. FACS analysis performed on thymocytes from 500-cGy-treated mice showed a sizeable decrease in the cell numbers of all subpopulations, mostly of the CD4 + CD8 ' cell subset. Recovery induced by 11,-3 was complete for the CD4 CD8 and CD4'CD8 ' cell subsets whereas the numbers ofCD4-CD8' and CD4+CDX-cells approached normal values.
DISCUSSION
Irradiation induces thymocyte depletion mostly in the cortical region, resulting in an elevated ratio between medullary and cortical lymphoid cells. Sublethal radiation damage is transient as the regeneration of the irradiated thymus is remarkably rapid. This regeneration process depends not only on stem cell mobilization in the BM, migration to the thymus, and differentiation to mature T lymphocytes, but also on the proliferation of intrdthymic radioresistant precursors. Thus, 7 to IO days after irradiation, radioresistant 
BM stem cells colonize the thymus where they remain resting for 7 to 10 days before entering the cell cycle.19 Before this time, intrathymic radioresistant precursors are responsible for the first phase of cellular reconstitution.20
In the present study, we have investigated the possibility of accelerating lymphocyte regeneration after sublethal irradiation by injecting mice with IL-3, a cytokine involved in the survival, proliferation, and differentiation of multipotent BM cells. The results presented herein show that IL-3 injection in mice exposed to different doses of sublethal irradiation induced in the thymus complete recovery of the cell count and proliferative response to mitogens. These data are in line with the hypothesis" that IL-3 potentiates stem cell migration to the thymus or induces stem cell proliferation and differentiation in the thymus. As previously described,22 very few stem cells can give rise to optimal Tcell development in a sublethally irradiated thymus if exogenous growth factors are provided. Results from experiments performed with mice sublethally irradiated and reconstituted with intrathymic injection of BM cells have further shown that the myeloid progeny of injected stem cells effectively contributes to the milieu in terms of growth factors and cellular interactions that drive T-cell differentiation.22
The effects of IL-3 on thymocytes may result from multiple mechanisms. Experiments performed to investigate the presence of IL-3 receptors on thymus T cells were u n s u~c e s s f u l~*~~ suggesting that the observed effects of IL-3 on thymocytes may be a consequence of IL-3-driven modulation of other cell types in the thymus. Injection of IL-3 in irradiated mice may have induced the synthesis and secretion of other biologically active molecules by accessory cells in thymus and spleen. In the thymus, IL-3 may stimulate IL-6 production by macrophages and dendritic cells, which strongly potentiates the expression of major histocompatibility complex (MHC) molecules on both accessory cell types necessary for T-cell differentiati~n.~~ The interaction between MHC class I and I1 molecules and CD8 and CD4 molecules, respectively, leads to the selection of mature T cells. Macrophages and dendritic cells may also produce IL-1, a cytokine with an amplifying rather than initiating role in T-cell pr~liferation.~~ Furthermore, IL-1 synergizes with IL-6 to promote T-cell activation.26 Moreover, macrophages may modulate dendritic cell functions through the release of cytokines that bind to specific receptors on the surface of dendritic cells. 27 Our results show that also in the spleen the cell count and mitotic responsiveness to Con A and LPS were recovered by In conclusion, the results presented herein show that injection of I L 3 into sublethally irradiated mice accelerates the regeneration of thymus and spleen cellularity and completely recovers T-and B-cell functions. The effect of IL-3 is quite evident, even when mice are exposed to relatively high doses of x-rays, provided that the time interval between irradiation and death is prolonged (Fig 3) . Results from these studies may significantly contribute to the identification of the conditions for optimal intervention after radiotherapy to accelerate recovery of the immune system and to prevent radiation death.
